Preventive Effect of H.Pylori Eradication on Osteoporosis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

846 participants

Study Classification

OBSERVATIONAL

Study Start Date

2003-05-31

Study Completion Date

2023-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this study, the investigators observed the long-term incidence rate of osteoporosis in patients who received Helicobacter pylori eradication and examined differences by age and sex.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Influence of Helicobacter Pylori Eradication on Gastric Pathology: a Long-term, Prospective Cohort Study

NCT02933229

Helicobacter Pylori the Operative Link on Gastric Intestinal Metaplasia Operative Link on Gastric Intestinal Assessment

NOT_YET_RECRUITING PHASE4

Association of Oral Helicobacter Pylori Infection With Gastric Helicobacter Pylori Infection

NCT05790512

Helicobacter Pylori

COMPLETED

Helicobacter Pylori and Proton Pump Inhibitor

NCT02449941

Helicobacter Infections

COMPLETED

Application of Artificial Intelligence on the Diagnosis of Helicobacter Pylori Infection and Premalignant Gastric Lesion

NCT05762991

Helicobacter Pylori Infection Premalignant Lesion

RECRUITING

Efficacy Study of Helicobacter Pylori Eradication in Patients Undergoing Subtotal Gastrectomy for Gastric Cancer

NCT01002443

Gastric Cancer

COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In this study, the investigators observed the long-term incidence rate of osteoporosis in patients who received Helicobacter pylori eradication and examined differences by age and sex. In addition, the investigators will analyze the correlation between the incidence of osteoporosis by comparing confounding factors such as body mass index, steroid use, and proton pump inhibitor use as well as the eradication status of H. pylori.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HELICOBACTER PYLORI INFECTIONS Osteoporosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Eradicated group

Helicobacter pylori eradication was successfully achieved.

DEXA(Dual-Energy X-ray Absorptiometry)

Intervention Type DIAGNOSTIC_TEST

Followed for up to 20 years

Non-eradicated group

Helicobacter pylori eradication was not successfully achieved.

DEXA(Dual-Energy X-ray Absorptiometry)

Intervention Type DIAGNOSTIC_TEST

Followed for up to 20 years

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

DEXA(Dual-Energy X-ray Absorptiometry)

Followed for up to 20 years

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

ㆍPatients tested Helicobacter pylori status

Exclusion Criteria

ㆍPatients aged \< 20 years ㆍPatients with unknown Helicobacter pylori bone density status ㆍPatients with with a history of gastric cancer ㆍPatients with prior Helicobacter pylori eradication therapy ㆍPatients with a history of osteoporosis

Minimum Eligible Age

20 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No